War and Military Atlas

How Battles Were Fought
Sign In
Text size
100%
Theme
Weapons System

M982 Excalibur

Artillery And Mortars

The M982 Excalibur, earlier called the XM982, is a 155 mm extended-range guided artillery shell developed jointly by the US Army Research Laboratory and the Armament Research, Development and Engineering Center. Raytheon supplied the guidance system and the Swedish BAE Systems Bofors the body, base, ballistics and payload. The round steers by GPS and inertial guidance, gliding on folding fins from the top of its ballistic arc, which lets gunners hit targets within 75 to 150 meters of friendly troops or near civilians where unguided shells would be unsafe. Its range runs from roughly 40 to 57 kilometers by configuration, with a circular error probable of about 4 meters, and a December 2020 test reached 70 kilometers from an extended-range gun tube. Increment Ia-1 entered service in 2007 and saw its first combat in Iraq that summer. Variants add laser guidance, a 127 mm naval version, an armor-piercing warhead and a shaped-trajectory mode. The shell has been used in Ukraine, where Russian electronic warfare sharply cut its early accuracy.

Facts
Classification
Caliber
155mm 1
Service Status
In Service 1
Weapon Class
Weapon Class (category)
Howitzer / Artillery 1
Introduced Year
2007 1
Connections

Operated By

Source M982 Excalibur (Wikipedia)

Used In

Iraq War, Wars
Source M982 Excalibur (Wikipedia)
Sources
1. M982 Excalibur (Wikipedia)
  • Lead
    extended-range guided artillery shell
  • Variants
    Increment Ia-1: Accelerated development, reduced-range round. Entered service in 2007.
  • Lead [caliber]
    is a 155 mm (6.1 in) extended-range guided artillery shell
  • Description
    Excalibur ammunition was also used with AHS Krab in 2022 in combat in Ukraine
  • Operated By: United States Army, Description [operated-by]
    the US Army planned to increase production to 150 rounds per month
View the Source
Comments (0)
No comments yet. Be the first to share a thought.
Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.